Centessa Pharmaceuticals plc reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 50.71 million compared to USD 54.5 million a year ago. Basic loss per share from continuing operations was USD 0.53 compared to USD 0.6 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.18 USD | +2.52% | +15.68% | +27.89% |
10/06 | Centessa Pharmaceuticals Appoints John Crowley as CFO | MT |
10/06 | Centessa Pharmaceuticals plc Announces Chief Financial Officer Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.89% | 1.15B | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- CNTA Stock
- News Centessa Pharmaceuticals plc
- Centessa Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2023